INKT · MiNK Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| AGENUS INC 10% Owner | ▲ Buy | Open Market | 21,772,863 Shares held | 10/16/2023 | View profile |
| Garo H. Armen Chairman and CEO | ▼ Sell | Open Market | 1,866,400 Shares held | 5/5/2023 | View profile |
| Jennifer Buell Chief Executive Officer | ▲ Buy | Grant | 67,966 Shares held | 1/2/2026 | View profile |
| Brian Corvese Director | ▲ Buy | Grant | 54,770 Shares held | 9/1/2026 | View profile |
| Baldoni John Director | ▲ Buy | Grant | 41,193 Shares held | 9/1/2023 | View profile |
| van Dijk Marcus Antonius Chief Scientific Officer | ▼ Sell | Tax Withholding | 27,363 Shares held | 1/9/2023 | View profile |
| Peter Behner Director | ▲ Buy | Grant | 24,404 Shares held | 9/1/2026 | View profile |
| Ulf Wiinberg Director | ▲ Buy | Grant | 23,929 Shares held | 9/1/2026 | View profile |
| Barbara Ryan Director | ▲ Buy | Grant | 23,591 Shares held | 9/1/2026 | View profile |
| Robert Peter Kadlec | ▲ Buy | Grant | 19,126 Shares held | 12/1/2025 | View profile |
| John Bradley Holcomb | ▲ Buy | Grant | 4,691 Shares held | 9/1/2026 | View profile |
Transaction History
| Brian Corvese | ▲ Buy | Grant | 1,633 | $18K | 9/1/2026 |
| Ulf Wiinberg | ▲ Buy | Grant | 1,279 | $14K | 9/1/2026 |
| John Bradley Holcomb | ▲ Buy | Grant | 1,233 | $14K | 9/1/2026 |
| Peter Behner | ▲ Buy | Grant | 1,485 | $16K | 9/1/2026 |
| Barbara Ryan | ▲ Buy | Grant | 1,622 | $18K | 9/1/2026 |
| Barbara Ryan | ▼ Sell | Open Market | 500 | $6K | 6/4/2026 |
| Barbara Ryan | ▼ Sell | Open Market | 1,000 | $13K | 6/4/2026 |
| John Bradley Holcomb | ▲ Buy | Grant | 1,091 | $14K | 6/1/2026 |
| Barbara Ryan | ▲ Buy | Grant | 1,434 | $18K | 6/1/2026 |
| Brian Corvese | ▲ Buy | Grant | 1,444 | $18K | 6/1/2026 |
| Peter Behner | ▲ Buy | Grant | 1,313 | $16K | 6/1/2026 |
| Ulf Wiinberg | ▲ Buy | Grant | 1,131 | $14K | 6/1/2026 |
| Barbara Ryan | ▼ Sell | Open Market | 300 | $5K | 3/10/2026 |
| Barbara Ryan | ▼ Sell | Open Market | 500 | $8K | 3/10/2026 |
| Barbara Ryan | ▼ Sell | Open Market | 500 | $8K | 3/10/2026 |
| Barbara Ryan | ▼ Sell | Open Market | 200 | $2K | 3/9/2026 |
| Barbara Ryan | ▼ Sell | Open Market | 100 | $1K | 3/2/2026 |
| John Bradley Holcomb | ▲ Buy | Grant | 1,239 | $14K | 3/2/2026 |
| Barbara Ryan | ▲ Buy | Grant | 1,629 | $18K | 3/2/2026 |
| Brian Corvese | ▲ Buy | Grant | 1,640 | $18K | 3/2/2026 |
| Peter Behner | ▲ Buy | Grant | 1,491 | $16K | 3/2/2026 |
| Ulf Wiinberg | ▲ Buy | Grant | 1,285 | $14K | 3/2/2026 |
| Barbara Ryan | ▼ Sell | Open Market | 400 | $4K | 2/27/2026 |
| Jennifer Buell | ▲ Buy | Grant | 31,474 | $350K | 1/2/2026 |
| Brian Corvese | ▲ Buy | Grant | 1,612 | $18K | 12/1/2025 |
| Peter Behner | ▲ Buy | Grant | 1,466 | $16K | 12/1/2025 |
| Barbara Ryan | ▲ Buy | Grant | 1,601 | $18K | 12/1/2025 |
| John Bradley Holcomb | ▲ Buy | Grant | 1,128 | $13K | 12/1/2025 |
| Robert Peter Kadlec | ▲ Buy | Grant | 1,218 | $14K | 12/1/2025 |
| Ulf Wiinberg | ▲ Buy | Grant | 1,263 | $14K | 12/1/2025 |
| Jennifer Buell | ▲ Buy | Grant | 18,229 | $280K | 9/9/2025 |
| Ulf Wiinberg | ▲ Buy | Grant | 1,011 | $14K | 9/2/2025 |
| Robert Peter Kadlec | ▲ Buy | Grant | 975 | $14K | 9/2/2025 |
| Barbara Ryan | ▲ Buy | Grant | 1,281 | $18K | 9/2/2025 |
| Brian Corvese | ▲ Buy | Grant | 1,290 | $18K | 9/2/2025 |
| Peter Behner | ▲ Buy | Grant | 1,173 | $16K | 9/2/2025 |
| Brian Corvese | ▲ Buy | Grant | 2,494 | $18K | 6/2/2025 |
| Peter Behner | ▲ Buy | Grant | 2,267 | $16K | 6/2/2025 |
| Robert Peter Kadlec | ▲ Buy | Grant | 1,883 | $14K | 6/2/2025 |
| Ulf Wiinberg | ▲ Buy | Grant | 1,953 | $14K | 6/2/2025 |
| Barbara Ryan | ▲ Buy | Grant | 2,476 | $18K | 6/2/2025 |
| Robert Peter Kadlec | ▲ Buy | Grant | 1,536 | $14K | 3/3/2025 |
| Peter Behner | ▲ Buy | Grant | 1,849 | $16K | 3/3/2025 |
| Ulf Wiinberg | ▲ Buy | Grant | 1,593 | $14K | 3/3/2025 |
| Barbara Ryan | ▲ Buy | Grant | 2,019 | $18K | 3/3/2025 |
| Brian Corvese | ▲ Buy | Grant | 2,033 | $18K | 3/3/2025 |
| Brian Corvese | ▲ Buy | Grant | 24,400 | $18K | 12/1/2024 |
| Peter Behner | ▲ Buy | Grant | 20,987 | $15K | 12/1/2024 |
| Ulf Wiinberg | ▲ Buy | Grant | 20,476 | $15K | 12/1/2024 |
| Robert Peter Kadlec | ▲ Buy | Grant | 12,286 | $9K | 12/1/2024 |
| Barbara Ryan | ▲ Buy | Grant | 24,229 | $18K | 12/1/2024 |
| Barbara Ryan | ▲ Buy | Grant | 21,649 | $18K | 9/3/2024 |
| Ulf Wiinberg | ▲ Buy | Grant | 18,295 | $15K | 9/3/2024 |
| Brian Corvese | ▲ Buy | Grant | 21,802 | $18K | 9/3/2024 |
| Peter Behner | ▲ Buy | Grant | 18,753 | $15K | 9/3/2024 |
| Brian Corvese | ▲ Buy | Grant | 17,967 | $18K | 6/3/2024 |
| Ulf Wiinberg | ▲ Buy | Grant | 15,077 | $15K | 6/3/2024 |
| Peter Behner | ▲ Buy | Grant | 15,454 | $15K | 6/3/2024 |
| Barbara Ryan | ▲ Buy | Grant | 17,841 | $18K | 6/3/2024 |
| Peter Behner | ▲ Buy | Grant | 16,185 | $15K | 3/1/2024 |
| Barbara Ryan | ▲ Buy | Grant | 18,685 | $18K | 3/1/2024 |
| Ulf Wiinberg | ▲ Buy | Grant | 15,790 | $15K | 3/1/2024 |
| Brian Corvese | ▲ Buy | Grant | 18,816 | $18K | 3/1/2024 |
| Peter Behner | ▲ Buy | Grant | 14,784 | $15K | 12/1/2023 |
| Barbara Ryan | ▲ Buy | Grant | 17,068 | $18K | 12/1/2023 |
| Brian Corvese | ▲ Buy | Grant | 17,188 | $18K | 12/1/2023 |
| Ulf Wiinberg | ▲ Buy | Grant | 14,424 | $15K | 12/1/2023 |
| AGENUS INC | ▲ Buy | Open Market | 429 | $472 | 10/16/2023 |
| AGENUS INC | ▲ Buy | Open Market | 19,373 | $21K | 10/13/2023 |
| AGENUS INC | ▲ Buy | Open Market | 3,173 | $3K | 10/12/2023 |
| Jennifer Buell | ▼ Sell | Other | 695,750 | — | 10/11/2023 |
| AGENUS INC | ▲ Buy | Open Market | 15,001 | $16K | 10/4/2023 |
| Jennifer Buell | ▼ Sell | Tax Withholding | 65,000 | $61K | 10/3/2023 |
| Jennifer Buell | ▼ Sell | Tax Withholding | 58,550 | $61K | 10/2/2023 |
| Jennifer Buell | ▼ Sell | Tax Withholding | 25,000 | $29K | 9/29/2023 |
| Jennifer Buell | ▲ Buy | Option Exercise | 695,750 | — | 9/27/2023 |
| Baldoni John | ▲ Buy | Grant | 9,846 | $14K | 9/1/2023 |
| Barbara Ryan | ▲ Buy | Grant | 12,158 | $18K | 9/1/2023 |
| Ulf Wiinberg | ▲ Buy | Grant | 9,590 | $14K | 9/1/2023 |
| Brian Corvese | ▲ Buy | Grant | 12,244 | $18K | 9/1/2023 |
| Peter Behner | ▲ Buy | Grant | 10,531 | $15K | 9/1/2023 |
| AGENUS INC | ▲ Buy | Open Market | 29,678 | $45K | 8/29/2023 |
| AGENUS INC | ▲ Buy | Open Market | 12,808 | $19K | 8/28/2023 |
| AGENUS INC | ▲ Buy | Open Market | 170,244 | $263K | 8/24/2023 |
| Brian Corvese | ▲ Buy | Grant | 10,157 | $18K | 6/1/2023 |
| Barbara Ryan | ▲ Buy | Grant | 10,086 | $18K | 6/1/2023 |
| Baldoni John | ▲ Buy | Grant | 8,168 | $14K | 6/1/2023 |
| Peter Behner | ▲ Buy | Grant | 8,736 | $15K | 6/1/2023 |
| Ulf Wiinberg | ▲ Buy | Grant | 7,955 | $14K | 6/1/2023 |
| AGENUS INC | ▲ Buy | Open Market | 23,361 | $33K | 5/11/2023 |
| AGENUS INC | ▲ Buy | Open Market | 22,065 | $33K | 5/10/2023 |
| Garo H. Armen | ▼ Sell | Open Market | 100,000 | $95K | 5/5/2023 |
| AGENUS INC | ▲ Buy | Open Market | 100,000 | $95K | 5/5/2023 |
| AGENUS INC | ▲ Buy | Open Market | 200 | $250 | 5/5/2023 |
| AGENUS INC | ▲ Buy | Open Market | 21,473 | $26K | 5/4/2023 |
| AGENUS INC | ▲ Buy | Open Market | 128,689 | $139K | 5/3/2023 |
| Garo H. Armen | ▲ Buy | Open Market | 100,000 | $95K | 5/2/2023 |
| AGENUS INC | ▼ Sell | Other | 4,988,273 | $0 | 5/1/2023 |
| Ulf Wiinberg | ▲ Buy | Grant | 6,699 | $14K | 3/1/2023 |
| Baldoni John | ▲ Buy | Grant | 6,878 | $14K | 3/1/2023 |
| Barbara Ryan | ▲ Buy | Grant | 8,493 | $18K | 3/1/2023 |
| Peter Behner | ▲ Buy | Grant | 7,357 | $15K | 3/1/2023 |
| Brian Corvese | ▲ Buy | Grant | 8,553 | $18K | 3/1/2023 |
| Jennifer Buell | ▲ Buy | Grant | 171,990 | $399K | 1/9/2023 |
| van Dijk Marcus Antonius | ▲ Buy | Grant | 51,628 | $120K | 1/9/2023 |
| van Dijk Marcus Antonius | ▼ Sell | Tax Withholding | 24,265 | $56K | 1/9/2023 |
| Peter Behner | ▲ Buy | Grant | 5,891 | $15K | 12/1/2022 |
| Ulf Wiinberg | ▲ Buy | Grant | 5,364 | $14K | 12/1/2022 |
| Baldoni John | ▲ Buy | Grant | 5,508 | $14K | 12/1/2022 |
| Brian Corvese | ▲ Buy | Grant | 6,849 | $18K | 12/1/2022 |
| Barbara Ryan | ▲ Buy | Grant | 6,801 | $18K | 12/1/2022 |
| Ulf Wiinberg | ▲ Buy | Grant | 10,688 | $28K | 9/15/2022 |
| Baldoni John | ▲ Buy | Grant | 10,974 | $29K | 9/15/2022 |
| Peter Behner | ▲ Buy | Grant | 11,737 | $31K | 9/15/2022 |
| Barbara Ryan | ▲ Buy | Grant | 13,550 | $36K | 9/15/2022 |
| Brian Corvese | ▲ Buy | Grant | 13,646 | $36K | 9/15/2022 |
| Ulf Wiinberg | ▲ Buy | Open Market | 16,661 | $23K | 7/19/2022 |
| Ulf Wiinberg | ▲ Buy | Open Market | 3,339 | $4K | 7/18/2022 |
| AGENUS INC | ▲ Buy | Open Market | 1,400,000 | $16.8M | 10/19/2021 |
| AGENUS INC | ▼ Sell | Other | 5,451,958 | — | 10/19/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
MiNK Therapeutics Chosen for ARPA‑H Cell Therapy Initiative
MiNK Therapeutics was selected by ARPA‑H for a funded initiative that aims to develop room‑temperature cell therapies. The partnership gives the company access to research resources and potential collaboration with other biotech firms. This could accelerate the progress of MiNK’s cell‑based products and increase investor interest in the company’s pipeline.
MiNK Therapeutics Chosen for ARPA‑H Cell Therapy Initiative. MiNK Therapeutics was selected by ARPA‑H for a funded initiative that aims to develop room‑temperature cell therapies. The partnership gives the company access to research resources and potential collaboration with other biotech firms. This could accelerate the progress of MiNK’s cell‑based products and increase investor interest in the company’s pipeline.